Is it Time to Dump Tandem Diabetes Care Inc (TNDM) Stock After it Has Gained 12.30% in a Week?

The market has been high on Tandem Diabetes Care Inc (TNDM) stock recently. TNDM gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Tandem Diabetes Care Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TNDM!

See Full TNDM Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TNDM Stock Today?

Tandem Diabetes Care Inc (TNDM) stock has gained 0.44% while the S&P 500 is lower by -0.08% as of 10:48 AM on Wednesday, Dec 8. TNDM is up $0.62 from the previous closing price of $139.38 on volume of 48,930 shares. Over the past year the S&P 500 is up 26.84% while TNDM is up 54.03%. TNDM earned $0.34 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 408.43. To screen for more stocks like Tandem Diabetes Care Inc click here.

More About Tandem Diabetes Care Inc

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States. Click Here to get the full Stock Report for Tandem Diabetes Care Inc stock.